Position in AMGN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$5,938,768
-$2,013,042 QoQ
Shares Held
16,400
-27.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#759
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PKO Investment Management Joint-Stock Co holds $45,805,043 across 9 Drug Manufacturers - General names. AMGN ranks #4 (13.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,750 | $10,495,013 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
58,500 | $7,390,890 | |
| 3 | JNJ |
Johnson & Johnson
|
28,200 | $7,161,954 | |
| 4 | AMGN |
Amgen Inc
This page
|
16,400 | $5,938,768 | |
| 5 | ABBV |
AbbVie Inc.
|
21,200 | $5,334,768 | |
| 6 | PFE |
Pfizer Inc
|
166,450 | $4,008,116 | |
| 7 | MRK |
Merck & Co., Inc.
|
30,000 | $3,855,000 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
21,000 | $1,210,020 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,938,768 | 16,400 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $7,951,810 | 22,600 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $8,019,095 | 24,500 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $10,909,852 | 38,660 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $9,844,944 | 35,260 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,679,330 | 8,600 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $5,681,952 | 21,800 | Shares | Sole | 2025-03-13 | |
| 2024-09-30 | $2,964,332 | 9,200 | Shares | Sole | 2025-03-13 | |
| 2024-06-30 | $3,186,990 | 10,200 | Shares | Sole | 2025-03-13 | |
| 2024-03-31 | $3,354,976 | 11,800 | Shares | Sole | 2025-03-13 | |
| 2023-12-31 | $2,736,190 | 9,500 | Shares | Sole | 2025-03-13 | |
| 2023-09-30 | $671,900 | 2,500 | Shares | Sole | 2025-03-13 | |
| 2023-06-30 | $6,046,270 | 27,233 | Shares | Sole | 2025-03-13 | |
| 2023-03-31 | $4,109,750 | 17,000 | Shares | Sole | 2025-03-13 | |
| 2022-12-31 | $919,240 | 3,500 | Shares | Sole | 2025-03-13 | |
| 2022-09-30 | $1,352,400 | 6,000 | Shares | Sole | 2025-03-13 | |
| 2022-06-30 | $1,216,500 | 5,000 | Shares | Sole | 2025-03-13 | |
| 2022-03-31 | $1,692,740 | 7,000 | Shares | Sole | 2025-03-13 | |
| 2021-12-31 | $5,794,777 | 25,758 | Shares | Sole | 2025-03-13 | |
| 2021-09-30 | $3,984,635 | 18,738 | Shares | Sole | 2025-03-13 | |
| 2021-06-30 | $3,505,125 | 14,380 | Shares | Sole | 2025-03-13 | |
| 2021-03-31 | $1,599,848 | 6,430 | Shares | Sole | 2025-03-13 | |
| 2020-12-31 | $1,478,385 | 6,430 | Shares | Sole | 2025-03-13 | |
| 2020-09-30 | $1,634,248 | 6,430 | Shares | Sole | 2025-03-13 | |
| 2020-06-30 | $1,516,579 | 6,430 | Shares | Sole | 2025-03-13 | |
| 2020-03-31 | $1,303,553 | 6,430 | Shares | Sole | 2025-03-13 | |
| No filing history on record for this holder in this stock. | ||||||